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A Case of Lance-Adams Syndrome:  
The Clinical Process of the Evidence-Based Clinician 
 
Annette Askren and Paula Leslie 
 
Abstract  
Evidence-based practice (EBP) has become a hallmark of modern medicine. Diving into the literature is an essential part of clinical 
decision-making. The management of rare disorders and disease almost always prompts a search, but the answers to important 
clinical questions can be challenging and rarely straightforward. The majority of us have endured the “EBP Class” of our academic 
careers, drilling the hierarchy of research evidence and whether strict inclusion/exclusion criteria were considered, etc. We 
frequently see our medical colleagues turn to high powered trials and meta-analyses, but such works are few and far between. 
Single-subject design, case studies, case series, and reviews of such cannot be discredited, especially within a profession that is 
relatively new in the broad scheme of medicine. The following case study details a clinician’s process through the identification, 
appraisal, and application of relevant literature in the management of a rare disorder: Lance-Adams syndrome. Proposed 
assessment considerations are intended to help the reader’s approach to diagnosis and intervention. 
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Learning Objectives  
1) Define Lance-Adams Syndrome and identify its 
associated communication and swallowing 
impairments.  
2) State the roles of the interdisciplinary team 
appropriate for individuals with Lance-Adams 
Syndrome. 
3) Summarize appropriate diagnostic considerations for 
swallowing and communication difficulties in 
individuals with Lance-Adams Syndrome. 
♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦ 
 
 
A 33-year-old male with newly diagnosed Lance-Adams 
syndrome (LAS) was referred to the speech-language 
pathology service to address communication and 
swallowing. The patient was admitted to a teaching 
hospital after being stabilized at an outside facility 
following heroin overdose. During the overdose, the 
patient went into cardiac arrest, and his spouse started 
cardio-pulmonary resuscitation. The patient was 
transported by ambulance to his community hospital 
where he remained unconscious and intubated with 
mechanical ventilation for four days. Continuous 
electroencephalography suggested status epilepticus. 
The patient was transferred to the teaching hospital 
two weeks thereafter. Following the transfer, he was 
awake and alert and resumed a regular-textured oral 
diet, ordered by the medical team.  
 
Records to this point were scattered. It was not until the 
patient was admitted to the teaching facility that clinical 
features consistent with LAS were observed. A chest 
radiograph revealed atelectasis, or reduced lung 
inflation, of the right lower lobe and developing 
pneumonia. Repeated radiograph one month later was 
normal. Repeated head imaging was also normal. The 
patient told his medical team that he was having 
trouble feeding himself and “getting [his] words out”, 
prompting our referral.   
 
The patient had a history of hepatitis C virus, substance 
abuse disorder (including alcohol), post-traumatic stress 
disorder, anxiety, depression, and tinnitus. The patient 
served four years in the United States Air Force after 
graduating from high school and was currently 
unemployed. He had four children and was living with 
his spouse prior to admission. The patient described his 
relationship as “rocky”.  
 
Inpatient medications included clonazepam, a 
benzodiazepine, and valproic acid, an antiepileptic drug. 
Both were prescribed to treat the myoclonic dyskinesia 
described later. Mirtazapine, an atypical antidepressant, 
and sertraline, a selective serotonin reuptake inhibitor, 
were both used to treat depression and generalized 
anxiety disorder (off-label). Clonidine was prescribed 
(off-label) to address opioid withdrawal. Heparin was 
prescribed as an anticoagulant. Thiamine was used to 
prophylactically treat thiamine-deficiency in the context 
of a known history of alcohol abuse.  
 
Supporting Research Evidence 
A search for best available evidence led to the 
databases PubMed, Google Scholar, and ASHA Wire. 
Combinations of relevant search terms were used: 
Lance-Adams syndrome, speech, swallowing, cognition, 
language, post hypoxic myoclonus, hyperkinetic, patient 
reported outcome. The search returned a series of case 
studies and systematic reviews. The following describes 
those deemed most pertinent to the case under 
discussion.  
 
LAS was first described in 1963 (Lance & Adams, 1963). 
Four patients sustained anoxic encephalopathy 
following either cardiac arrest or a prolonged airway 
obstruction. Similar disturbances in movement were 
observed amongst the patients after regaining 
consciousness. Volitional movement induced an 
arrhythmic course or fine jerking of a single or group of 
muscles. Movements were approximately one-fifth of a 
second in duration and labeled action or intention 
myoclonus. Voluntary motion was initiated well, but 
became quickly interrupted. Movement became 
increasingly chaotic and fragmented as it continued. 
Severity of the myoclonus was found to be grossly 
proportional to the precision of the task. Lance and 
Adams (1963) described the relevant examples of 
“conveying food to the mouth” and “drinking from a 
glass” (p. 117) as particularly difficult activities. 
Myoclonic movements ceased when patients relaxed. 
All four patients consistently maintained an ataxic gait.  
 
Lance and Adams (1963) hypothesized that the 
underlying neuropathophysiology included a repetitive 
firing of thalamocortical fibers, stemming from the 
ventrolateral thalamic nucleus. The ventrolateral 
thalamic nucleus plays a large role in mediating motor 
function. This area receives input from both the 
cerebellum and basal ganglia and projects to the 
primary motor and premotor cortices (Siegel & Sapru, 
2015). Abnormal firings through these projections are 
relayed to the corticobulbar and corticospinal tracts, 
producing action myoclonus (Duffy, 2013). Autopsies 
from Lance and Adams’s other deceased patients 
revealed that the globus pallidus, hippocampus, deep 
folia of the cerebellum, and deep layers of the cerebral 
cortex were structurally damaged by similar anoxic 
brain injuries. These areas, as well as the Purkinje cells 
of the cerebellum, were hypothesized to be damaged in 
LAS specifically.   
 
Lance and Adams’s (1963) paper is certainly dated, but 
they provide a descriptive review. Their description 
continues to be referenced as a standard definition of 
the syndrome in the most recent literature. The four 
patients that are described closely resemble the current 
case, making this evidence pertinent to diagnostic 
considerations.  
 
Gupta and Caviness (2016) conducted the most recent 
systematic review of the LAS literature. The authors 
concluded that the neuropathophysiology and the 
neuroanatomy implicated remains poorly understood. 
Imaging studies collectively identified a wide variety of 
damaged neuroanatomy, including the basal ganglia, 
parietal lobes, and hippocampus. Some findings were 
even transient, resolving after repeating their imaging 
studies weeks later. Seizures were often observed in the 
acute comatose stage following a hypoxic event. Onset 
of LAS symptoms was observed days to weeks 
thereafter. LAS was found to be associated with 
dysarthria, dysphagia, seizures, cognitive deficits, and 
gait disturbances. Unfortunately, these impairments of 
significant interest to the speech-language pathologist 
were not well described. The collective literature 
indicated LAS responded well to benzodiazepines and 
anticonvulsant drugs. The syndrome typically persisted 
indefinitely.  
 
Lee and Lee (2011) published a case report describing a 
patient strikingly similar to the current case. A 32-year-
old male went into cardiac arrest after attempting to 
hang himself. He was successfully resuscitated and 
transferred to his community hospital. Computed 
tomography of the head was normal.  
Electroencephalography revealed status epilepticus. On 
day-12 of his hospitalization the patient regained 
consciousness, but he displayed action myoclonus. 
Performance on the Mini-Mental State Examination 
(Folstein et al., 1975) improved from a total score of 19 
out of 30 (moderate impairment) to 22 out of 30 (mild 
impairment) by discharge. Coupled with pharmacologic 
intervention, rehabilitation focused on voluntarily 
slowing volitional movement. This approach 
successfully reduced myoclonic jerking. By discharge, 
the patient was able to walk 20 meters with the 
assistance of a rolling walker. His dysarthria persisted.  
 
Possible Impairments 
Understanding the basic underlying nature of LAS and 
its known consequences can guide the evidence-based 
clinician. The case history and review of relevant 
external evidence suggests diagnostic hypotheses 
implicating oropharyngeal swallowing, motor speech, 
and cognitive-communication. 
 
Swallowing 
The literature identified action myoclonus, a dyskinesia, 
as the primary feature of LAS. Dyskinesias, like those in 
LAS, may result in dyscoordination of the oropharyngeal 
swallow (Stierwalt, 2013). The muscle relaxant and 
sedative properties of the benzodiazepine (clonazepam) 
and anticonvulsant (valproic acid) could contribute to 
both dyscoordination and inattention. Atypical 
antidepressants (mirtazapine) may also cause sedation. 
Side effects are often amplified in the setting of liver 
dysfunction (Carl & Johnson, 2006). Lance and Adams 
(1963) described relatively fine motor movement 
resulting in proportionally worse myoclonic jerking. The 
ability to self-feed would be impacted.  
 
Speech 
Motor speech impairment is very likely to be observed, 
specifically hyperkinetic dysarthria. Experts suggest 
dysarthria associated with action myoclonus may have a 
greater functional effect on speech production, as 
compared to the more familiar palatopharyngeal 
myoclonus (Duffy, 2013). Aronson, O’Neill, and Kelly 
described their own four cases of LAS (as cited in Duffy, 
2013). Their patients demonstrated fluctuations in 
phonation, and the aberrant phonatory function synced 
with action myoclonic movement of the lips. Sudden 
voice arrests, generally slow rate of speech, and 
articulatory imprecision when rate increased would 
therefore likely be observed in the current case (Duffy, 
2013). Errors would be highly variable and increase in 
occurrence with longer utterances.  
 
Cognitive-Communication  
The etiology of LAS suggests cognitive-communication 
impairment should also be considered. Plans for 
intervention may be directly impacted by such findings. 
Studies sporadically implicated structures of the basal 
ganglia and cerebellum among other areas. Both the 
basal ganglia and cerebellum have been found to play a 
role in cognitive functioning (Middleton & Strick, 2000). 
A review of long-term consequences associated with 
hypoxic-ischemic encephalopathy indicated a range of 
severity of cognitive impairments has been observed 
(Khot & Tirshwell, 2006). A reversible metabolic 
encephalopathy has been reported after relatively brief 
periods of circulatory arrest. This transient difficulty, 
characterized by a short period of confusion, or at least 
improvement in functioning, as described in the case by 
Lee and Lee (2011), may be expected in the current 
case.  
 
Conclusions: Diagnostic Considerations 
The comprehensive speech-language pathology 
evaluation will vary amongst clinicians. The following 
points are intended to assist the evidence-based 
clinician shape the assessment plan in consideration of 
the literature.   
 
Clinical examination of the oropharyngeal swallow is an 
essential start. The gross impact of the action 
myoclonus and medication effects on feeding and 
swallowing must be considered prior to a potentially 
complicated transport to a radiology suite 
(videofluoroscopic swallow study) or more invasive 
nasendoscopy (fiberoptic endoscopic evaluation of 
swallowing). Severe onset of jerking movements while 
eating and drinking may impede a clinician’s ability to 
capture a meaningful instrumental assessment. The 
clinical exam can also provide opportunity to trial 
optimal posturing and plans for feeding during an 
anticipated instrumental assessment. Medication 
changes may be made frequently, and clinical re-
assessment will be necessary.  
 
Assessment of cognitive-communication skills should 
consider medication effects, medication changes, and 
the action myoclonus itself. As mentioned previously, 
many drugs have sedating effects and may directly 
contribute to inattention. Selection and administration 
of standardized measures must consider the difficulties 
that movement of the upper extremities pose (e.g., 
trail-making task). 
 
An interdisciplinary approach will be essential to 
maximizing this patient’s outcomes. Referral to and 
close collaboration with allied rehabilitation providers 
should be of high priority. The American Speech-
Language-Hearing Association supports our role as 
“Case Manager” in individuals with cognitive-
communication impairments (ASHA, 2005). The speech-
language pathologist may assist with establishing the 
team and the effective communication amongst the 
following essential members. Specific implications for 
the speech-language pathologist are proposed: 
• Physicians. Close collaboration will clarify 
medication effects and changes. This may 
incorporate Pharmacists. Plans for the patient’s 
disposition, ordered by the physician, must 
consider all team members’ observations.  
• Occupational Therapists. Adaptive feeding and 
writing devices will directly affect the speech-
language pathologist’s assessments and 
interventions.  
• Physical Therapists. Optimal positioning 
recommendations and management of action 
myoclonus of the upper extremities may 
improve ability to capture meaningful 
evaluations (e.g., videofluoroscopic swallow 
study). 
• Mental Health Team/Social Workers. 
Establishing substance abuse treatment is 
essential to maximize long-term success. 
Counseling should consider the transition into 
a sudden, permanent disability and its effect 
on mental well-being.   
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